Bisphosphonate osteonecrosis of the jaw: a literature review of UK policies versus international policies on the management of bisphosphonate osteonecrosis of the jaw.
Despite the increasing number of cases of osteonecrosis of the jaws related to bisphosphonate therapy described in the literature there is a paucity of evidence-based treatment for the condition. In this second article on bisphosphonate-related jaw complications we discuss the different treatment strategies for the condition, review current literature, particularly in relation to the recommendations that have been published, and discuss the evidence behind them.
McLeod
Niall M H
NM
Oral & Maxillofacial Surgery Department, Queen Alexandra Hospital, Cosham, Portsmouth PO6 3LY, UK. niall_mcleod@yahoo.co.uk
Patel
Vinod
V
Kusanale
Atul
A
Rogers
Simon N
SN
Brennan
Peter A
PA
D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D055094:Evidence-Based Dentistry; D006291:Health Policy; D006801:Humans; D007571:Jaw Diseases / Q000139:chemically induced / Q000628:therapy*; D010020:Osteonecrosis / Q000139:chemically induced / Q000628:therapy*; D017410:Practice Guidelines as Topic; D006113:United Kingdom
D050071:Bone Density Conservation Agents; D004164:Diphosphonates